Biosimilars poised to make biologics more routine

The biosimilar age for rheumatology has arrived, and experts expect wider use of previously expensive biologic drugs as biosimilar competition drives prices down and makes biologics more...

Field of Interest: Rheumatology
Type: News Item

20-year follow-up supports adjuvant radiotherapy for DCIS

Adjuvant radiotherapy continues to protect against recurrences – ­albeit “modestly” – for a full 20 years after women undergo breast-conserving surgery for DCIS, according to a report published...

Field of Interest: Pulmonology
Type: News Item

20-year follow-up supports adjuvant radiotherapy for DCIS

Adjuvant radiotherapy continues to protect against recurrences – ­albeit “modestly” – for a full 20 years after women undergo breast-conserving surgery for DCIS, according to a report published...

Field of Interest: Oncology
Type: News Item

Drink more coffee to prevent a second BCC

AMSTERDAM – Liberal coffee consumption was independently associated with a reduced risk of developing a second basal cell carcinoma in individuals who’ve already had a first in an analysis from the...

Field of Interest: Geriatrics
Type: News Item

Drink more coffee to prevent a second BCC

AMSTERDAM – Liberal coffee consumption was independently associated with a reduced risk of developing a second basal cell carcinoma in individuals who’ve already had a first in an analysis from the...

Field of Interest: Dermatology
Type: News Item

FDA approves hepatitis C combination pill

The first combination pill to treat chronic hepatitis C virus genotype 1 infection was approved by the Food and Drug Administration Oct. 10. The once-daily tablet under the trade name Harvoni...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness